Services
Comprehensive Large Molecule Bioanalysis
We deliver end‑to‑end large molecule bioanalysis with deep scientific expertise, advanced assay platforms, and decades of experience supporting biologics programs.
Dedicated Large Molecule Expertise
We provide specialized large molecule bioanalysis across diverse biological matrices using ELISA and ECL (MSD) platforms, with fit‑for‑purpose method development, qualification, and validation.
Extensive PK/TK, ADA & NAb Capabilities
Comprehensive pharmacokinetic, toxicokinetic, anti‑drug antibody (ADA), and neutralizing antibody (NAb) assays for biologics and biosimilars.
Method Development & Validation Expertise
In‑house scientific teams design, develop, transfer, and optimize bioanalytical methods tailored for biologics.
Industry‑Leading Scale & Experience
We are a powerhouse in large molecule bioanalysis, shaped by decades of leadership, industry collaborations, and a dedicated team focused solely on large molecule programs.
Flexible, Client‑Centered Delivery
Our team adapts to the needs of each program—from exploratory biologics to complex clinical portfolios—bringing scientific insight and operational agility.
Leading Technologies & Platforms
Our platform diversity enables sensitive, reproducible, and regulatory‑aligned assays for complex biologics:
-
ELISA & ECL (MSD) immunoassays for quantitation and ADA/NAb characterization.
-
Broad Assay Menu for Biotherapeutics: Including antibodies, peptides, recombinant proteins, and other biologics prone to immune response.
-
Validated Large Molecule Methods: Robust qualification and validation approaches tailored to modality, matrix, and regulatory expectations.
Your Proven Partner for Complex Clinical Testing Needs
From antibodies and recombinant proteins to advanced biologic modalities, we deliver the scientific strength, operational scale, and regulatory alignment needed to move large molecule therapeutics forward.
Deep Large Molecule SpecializationOur teams focus exclusively on large molecule bioanalysis, offering unmatched depth across ADA monitoring, biologics PK, immunogenicity risk assessment, and biomarker integration.
Integrated GLP/GCP‑Aligned OperationsEurofins Viracor BioPharma has expanded its GLP/GCP bioanalytical capabilities within its purpose‑built, 11‑acre Lenexa facility—offering method development, validation, and regulated sample analysis in one streamlined environment.
Industry‑Leading InfrastructureOur newly expanded, state‑of‑the‑art laboratory space was engineered for high‑quality sample handling, stringent data integrity, and optimized workflows, ensuring reliability across complex clinical trials.
End‑to‑End Bioanalytical SupportIntegrated laboratory teams, harmonized contracting, and unified technologies reduce operational complexity and create a seamless experience from early development through late‑stage clinical programs.
Scalable Capacity for All Program SizesWhether supporting emerging biotech or late‑stage global trials, Eurofins provides flexible, high‑capacity resources to meet timelines and quality expectations.
Regulatory‑Ready DataAll services are compliant with global regulatory requirements and delivered through robust quality systems—ensuring submission‑ready data packages for biologics.
Experience You Can Trust
Our scientific and regulatory insight ensures your large molecule program is in expert hands.
Robust bioanalysis for ADC PK and immunogenicity, as well as custom biomarker assays for every stage of drug development.
Trusted biosimilar bioanalysis with proven assays and regulatory insight to support comparability, safety, and efficacy studies.
Comprehensive fusion protein bioanalysis with regulatory expertise to support development from pre-clinical to approval.
Expert immunogenicity bioanalysis with validated assays and regulatory support to advance innovative immune-based treatments.
Reliable ligand-binding assays for biologics, supporting PK, PD, and immunogenicity with validated, regulatory-compliant methods.
Specialized mAb bioanalysis with validated assays and deep expertise to support development, characterization, and regulatory success.
Ready to advance your biologic program?
